-5%
Montair is recommended for the following conditions:
- Long-term prevention and treatment of asthma
- Acute prevention of exercise-induced bronchospasm (EIB)
- Relief from symptoms of allergic rhinitis—both seasonal and perennial types
Montelukast is a selective leukotriene receptor antagonist that blocks the CysLT1 receptor, responsible for mediating inflammation. Leukotrienes (LTC4, LTD4, LTE4)—produced from arachidonic acid by mast cells and eosinophils—play a key role in asthma and allergic rhinitis symptoms like airway swelling, smooth muscle contraction, and inflammation. By inhibiting these effects, Montelukast helps reduce the severity of symptoms associated with these respiratory conditions.